Hochschulschrift
In vivo quiescence of delayed-contributing tumor-initiating cells and their role in chemotherapy resistance in colorectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
IX, 114 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Ruprecht-Karls-Universität Heidelberg, Dissertation, 2020
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wann)
-
[2020]
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 11:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Entstanden
- [2020]
Ähnliche Objekte (12)
Mechanisms of chemotherapy resistance in hepatocellular carcinoma
Factors contributing to artemisinin resistance in Plasmodium falciparum parasites
Chemotherapy resistance-associated mutations in acute myeloid leukemia
Sulforaphane as a chemosensitizer for standard-chemotherapy in experimental colorectal carcinoma
The role of ceramide synthases in chemotherapy and pathogenesis of colorectal cancer
LUBAC determines chemotherapy resistance in squamous cell lung cancer
Multifunctional nanoparticles for thermo-chemotherapy: impact of magnetic hyperthermia and 5-fluorouracil-based chemotherapy on colorectal carcinomas in mice
Unravelling epigenetic mechanisms of CAF-chemotherapy resistance in mammary carcinoma
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment
Molecular genetic alterations and multidrug resistance in human colorectal cancer
Chemotherapy
Genomic and non-genomic alterations in melanoma contributing to disease progression and therapy resistance
Mechanisms of chemotherapy resistance in hepatocellular carcinoma
Factors contributing to artemisinin resistance in Plasmodium falciparum parasites
Chemotherapy resistance-associated mutations in acute myeloid leukemia
Sulforaphane as a chemosensitizer for standard-chemotherapy in experimental colorectal carcinoma
The role of ceramide synthases in chemotherapy and pathogenesis of colorectal cancer
LUBAC determines chemotherapy resistance in squamous cell lung cancer
Multifunctional nanoparticles for thermo-chemotherapy: impact of magnetic hyperthermia and 5-fluorouracil-based chemotherapy on colorectal carcinomas in mice
Unravelling epigenetic mechanisms of CAF-chemotherapy resistance in mammary carcinoma
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment
Molecular genetic alterations and multidrug resistance in human colorectal cancer
Chemotherapy
Genomic and non-genomic alterations in melanoma contributing to disease progression and therapy resistance
Mechanisms of chemotherapy resistance in hepatocellular carcinoma
Factors contributing to artemisinin resistance in Plasmodium falciparum parasites
Chemotherapy resistance-associated mutations in acute myeloid leukemia
Sulforaphane as a chemosensitizer for standard-chemotherapy in experimental colorectal carcinoma
The role of ceramide synthases in chemotherapy and pathogenesis of colorectal cancer
LUBAC determines chemotherapy resistance in squamous cell lung cancer
Multifunctional nanoparticles for thermo-chemotherapy: impact of magnetic hyperthermia and 5-fluorouracil-based chemotherapy on colorectal carcinomas in mice
Unravelling epigenetic mechanisms of CAF-chemotherapy resistance in mammary carcinoma
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment
Molecular genetic alterations and multidrug resistance in human colorectal cancer
Chemotherapy